News IXICO plc

Stocks

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. 06:56:39 2026-11-12 EST			5-day change	1st Jan Change
13.09 ^GBX	+0.68%		-9.73%	+11.40%

11-03	WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan	AN
11-02	EARNINGS AND TRADING: Cap-XX loss narrows; GS Chain loss balloons	AN

All News

Mentions Relevance

df550fc2204.CvELhkvwSyVN_KxnUHwc-9W-gZwZtTSW1lvyEkEHvg0.J7Ba9w6qG1w_m_MlCTN2iJDT9ct6mAOjlD3KcTVCiz9DskrKGaY4YiqW-Q

11-01	IXICO plc Wins £2.7 Million Phase 3 Contract in Huntington's Disease	CI
10-29	IXICO Plc Presents Research On Novel Methods To Reduce Unwanted Variability In Huntington?s Disease Biomarker Data	CI
10-22	Ixico Wins New Contract, Extension Totaling GBP1.5 Million	MT
10-22	IXICO plc Announces Two Contracts In Alzheimer?s Disease Worth £1.5 Million	CI
10-20	Ixico stock rises as forecasts full-year revenue and earnings beat	AN
10-20	WINNERS & LOSERS: Ixico beats expectations; Shearwater wins deal	AN
10-20	IXICO plc Raises Earnings Guidance for the Year Ending 30 September 2026	CI
10-01	IXICO plc Presents Advancements In Neuroimaging For Parkinson?s Disease At European Radiology Conference	CI
07-13	Ixico notes ending of Huntington's disease programmes	AN
07-13	WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump	AN
07-13	Ixico Says Two Huntington's Disease Programs Discontinued by Sponsors	MT
07-07	IXICO plc Provides Earnings Guidance for the Year Ending 30 September 2026	CI
07-07	Ixico ups guidance; Steppe Cement revenue up	AN
06-08	Ixico plc Announces Appointments on Scientific Advisory Board	CI
06-08	Ixico Has Enters into A Research Collaboration with the Paris Brain Institute	CI
05-21	IXICO plc, H1 2026 Earnings Call, May 19, 2026
05-21	BTG to beat expectations; Sabre backs outlook	AN
05-21	Ixico Bags New Contract, Extension Worth GBP1.3 Million	MT
05-21	Ixico announces contract win & extension with total value of £1.3 million over 2 years	RE
05-21	Ixico plc Announces Contract Win and Extension	CI
05-19	Ixico reaffirms growth guidance as half-year revenue rises	AN
05-19	Ixico remains focused on delivering on guidance of 15% revenue growth for full year	RE
05-19	Earnings Flash (IXI.L) Ixico plc Reports Fiscal H1 Revenue GBP3.9M	MT
05-19	IXICO plc Reaffirms Earnings Guidance for the Full Year 2026	CI
05-19	IXICO plc Reports Earnings Results for the Half Year Ended March 31, 2026	CI